Report of the ISTH registry on pregnancy and COVID-19-associated coagulopathy (COV-PREG-COAG).
No Thumbnail Available
All Authors
Kazi, S.
Othman, M.
Khoury, R.
Bernstein, PS.
Thachil, J.
Ciantar, E.
Ferrara, L.
Netto, M.
Abdul-Kadir, R.
Malinowski, AK.
LTHT Author
Ciantar, Etienne
LTHT Department
Obstetrics & Gynaecology
Women's Services
Women's Services
Non Medic
Publication Date
2024
Item Type
Journal Article
Language
Subject
Subject Headings
Abstract
Background: Concerns about COVID-19-associated coagulopathy (CAC) in pregnant individuals were raised in early pandemic.
Methods: An ISTH-sponsored COVID-19 coagulopathy in pregnancy (COV-PREG-COAG) international registry was developed to describe incidence of coagulopathy, VTE, and anticoagulation in this group.
Results: All pregnant patients with COVID-19 from participating centers were entered, providing 430 pregnancies for the first pandemic wave. Isolated abnormal coagulation parameters were seen in 20%; more often with moderate/severe disease than asymptomatic/mild disease (49% vs 15%; p < 0.0001). No one met the ISTH criteria for disseminated intravascular coagulopathy (DIC), though 5/21 (24%) met the pregnancy DIC score. There was no difference in antepartum hemorrhage (APH) with asymptomatic/mild disease versus moderate/severe disease (3.4% vs 7.7%; p = 0.135). More individuals with moderate/severe disease experienced postpartum hemorrhage (PPH) (22.4% vs 9.3%; p = 0.006). There were no arterial thrombotic events. Only one COVID-associated venous thromboembolism (VTE) was reported.
Conclusions: Low rates of coagulopathy, bleeding, and thrombosis were observed among pregnant people in the first pandemic wave.
Journal
Obstetric Medicine